Literature DB >> 22552208

Notes from the field: Identification of Vibrio cholerae serogroup O1, serotype Inaba, biotype El Tor strain - Haiti, March 2012.

.   

Abstract

On October 20, 2010, an outbreak of cholera was confirmed in Haiti for the first time in more than a century. As of April 10, 2012, a total of 534,647 cases, 287,656 hospitalizations, and 7,091 deaths have been reported in Haiti as a result of the outbreak. The Vibrio cholerae strain that caused the Haiti epidemic has been characterized as toxigenic V. cholerae, serogroup O1, serotype Ogawa, biotype El Tor.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22552208

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  8 in total

1.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Importance of cholera and other etiologies of acute diarrhea in post-earthquake Port-au-Prince, Haiti.

Authors:  Macarthur Charles; Glavdia G Delva; Jethro Boutin; Karine Severe; Mireille Peck; Marie Marcelle Mabou; Peter F Wright; Jean W Pape
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti.

Authors:  Lee S Katz; Aaron Petkau; John Beaulaurier; Shaun Tyler; Elena S Antonova; Maryann A Turnsek; Yan Guo; Susana Wang; Ellen E Paxinos; Fabini Orata; Lori M Gladney; Steven Stroika; Jason P Folster; Lori Rowe; Molly M Freeman; Natalie Knox; Mike Frace; Jacques Boncy; Morag Graham; Brian K Hammer; Yan Boucher; Ali Bashir; William P Hanage; Gary Van Domselaar; Cheryl L Tarr
Journal:  MBio       Date:  2013-07-02       Impact factor: 7.867

4.  Phylodynamic analysis of clinical and environmental Vibrio cholerae isolates from Haiti reveals diversification driven by positive selection.

Authors:  Taj Azarian; Afsar Ali; Judith A Johnson; David Mohr; Mattia Prosperi; Nazle M Veras; Mohammed Jubair; Samantha L Strickland; Mohammad H Rashid; Meer T Alam; Thomas A Weppelmann; Lee S Katz; Cheryl L Tarr; Rita R Colwell; J Glenn Morris; Marco Salemi
Journal:  MBio       Date:  2014-12-23       Impact factor: 7.867

5.  Major Shift of Toxigenic V. cholerae O1 from Ogawa to Inaba Serotype Isolated from Clinical and Environmental Samples in Haiti.

Authors:  Meer T Alam; Shrestha S Ray; Camille N Chun; Zahara G Chowdhury; Mohammed H Rashid; Valery E Madsen Beau De Rochars; Afsar Ali
Journal:  PLoS Negl Trop Dis       Date:  2016-10-07

6.  Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process.

Authors:  Stefan L Karlsson; Nicholas Thomson; Ankur Mutreja; Thomas Connor; Dipika Sur; Mohammad Ali; John Clemens; Gordon Dougan; Jan Holmgren; Michael Lebens
Journal:  PLoS Negl Trop Dis       Date:  2016-10-05

7.  Seroepidemiologic survey of epidemic cholera in Haiti to assess spectrum of illness and risk factors for severe disease.

Authors:  Brendan R Jackson; Deborah F Talkington; James M Pruckler; M D Bernadette Fouché; Elsie Lafosse; Benjamin Nygren; Gerardo A Gómez; Georges A Dahourou; W Roodly Archer; Amanda B Payne; W Craig Hooper; Jordan W Tappero; Gordana Derado; Roc Magloire; Peter Gerner-Smidt; Nicole Freeman; Jacques Boncy; Eric D Mintz
Journal:  Am J Trop Med Hyg       Date:  2013-10       Impact factor: 2.345

8.  Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012-2013.

Authors:  Maria W Steenland; Gerard A Joseph; Mentor Ali Ber Lucien; Nicole Freeman; Marisa Hast; Benjamin L Nygren; Eyal Leshem; Stanley Juin; Michele B Parsons; Deborah F Talkington; Eric D Mintz; John Vertefeuille; S Arunmozhi Balajee; Jacques Boncy; Mark A Katz
Journal:  Am J Trop Med Hyg       Date:  2013-10       Impact factor: 2.345
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.